Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease

NCT03854305 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: PRV-6527
DRUG: Placebo

Sponsor

Provention Bio, Inc.